Hims & Hers Health Cash on Hand 2020-2025 | HIMS
Hims & Hers Health cash on hand from 2020 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Hims & Hers Health cash on hand for the quarter ending March 31, 2025 was $0.323B, a 58.49% increase year-over-year.
- Hims & Hers Health cash on hand for 2024 was $0.3B, a 35.87% increase from 2023.
- Hims & Hers Health cash on hand for 2023 was $0.221B, a 23.02% increase from 2022.
- Hims & Hers Health cash on hand for 2022 was $0.18B, a 27.36% decline from 2021.
| Hims & Hers Health Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $300 |
| 2023 | $221 |
| 2022 | $180 |
| 2021 | $247 |
| 2020 | $100 |
| 2019 | $2 |
| 2018 | $0 |
| Hims & Hers Health Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $323 |
| 2024-12-31 | $300 |
| 2024-09-30 | $254 |
| 2024-06-30 | $227 |
| 2024-03-31 | $204 |
| 2023-12-31 | $221 |
| 2023-09-30 | $212 |
| 2023-06-30 | $193 |
| 2023-03-31 | $184 |
| 2022-12-31 | $180 |
| 2022-09-30 | $198 |
| 2022-06-30 | $195 |
| 2022-03-31 | $203 |
| 2021-12-31 | $247 |
| 2021-09-30 | $252 |
| 2021-06-30 | $317 |
| 2021-03-31 | $323 |
| 2020-12-31 | $100 |
| 2020-09-30 | $1 |
| 2020-06-30 | $1 |
| 2020-03-31 | $1 |
| 2019-12-31 | |
| 2019-09-30 | $2 |
| 2019-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.944B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.731B | 53.50 |
| Tempus AI (TEM) | United States | $11.403B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.673B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.222B | 65.97 |
| Privia Health (PRVA) | United States | $2.843B | 194.33 |
| Enovis (ENOV) | United States | $1.910B | 10.65 |
| Clover Health Investments (CLOV) | United States | $1.634B | 0.00 |
| Schrodinger (SDGR) | United States | $1.578B | 0.00 |
| Phreesia (PHR) | United States | $1.484B | 0.00 |
| Omnicell (OMCL) | United States | $1.387B | 24.47 |
| Azenta (AZTA) | United States | $1.269B | 58.98 |
| 10x Genomics (TXG) | United States | $1.058B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.626B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.615B | 0.00 |
| Talkspace (TALK) | United States | $0.494B | 147.50 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.391B | 0.00 |
| TruBridge (TBRG) | United States | $0.361B | 801.00 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.263B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.134B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.32 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |